These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21048494)

  • 1. Synthesis and activity evaluation of a new bestatin derivative LYP2 as an aminopeptidase N inhibitor.
    Luan Y; Wang Q; Liu N; Mou J; Jiao X; Fang H; Li M; Xu W
    Anticancer Drugs; 2011 Jan; 22(1):99-103. PubMed ID: 21048494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of 1,3,4-thiadiazole derivatives as aminopeptidase N inhibitors.
    Li SH; Li G; Huang HM; Xiong F; Mai X; Kuang BH; Liu CM; Tu GG
    Pharmazie; 2009 Feb; 64(2):67-70. PubMed ID: 19320275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel 3-phenylpropane-1,2-diamine derivates as inhibitors of aminopeptidase N (APN).
    Shang L; Wang Q; Fang H; Mu J; Wang X; Yuan Y; Wang B; Xu W
    Bioorg Med Chem; 2008 Dec; 16(23):9984-90. PubMed ID: 18996018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological evaluation of novel L-isoserine tripeptide derivatives as aminopeptidase N inhibitors.
    Pan H; Yang K; Zhang J; Xu Y; Jiang Y; Yuan Y; Zhang X; Xu W
    J Enzyme Inhib Med Chem; 2013 Aug; 28(4):717-26. PubMed ID: 22545941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel leucine ureido derivatives as inhibitors of aminopeptidase N (APN).
    Ma C; Jin K; Cao J; Zhang L; Li X; Xu W
    Bioorg Med Chem; 2013 Apr; 21(7):1621-7. PubMed ID: 23453219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel aminopeptidase N (APN/CD13) inhibitors derived from 3-phenylalanyl-N'-substituted-2,6-piperidinedione.
    Zhang X; Fang H; Zhu H; Wang X; Zhang L; Li M; Li Q; Yuan Y; Xu W
    Bioorg Med Chem; 2010 Aug; 18(16):5981-7. PubMed ID: 20637634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of novel L-lysine ureido derivatives as aminopeptidase N inhibitors.
    Su L; Fang H; Yang K; Xu Y; Xu W
    Bioorg Med Chem; 2011 Jan; 19(2):900-6. PubMed ID: 21194957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of novel flavone-8-acetic acid derivatives as reversible inhibitors of aminopeptidase N/CD13.
    Bauvois B; Puiffe ML; Bongui JB; Paillat S; Monneret C; Dauzonne D
    J Med Chem; 2003 Aug; 46(18):3900-13. PubMed ID: 12930151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting aminopeptidase N (APN/CD13) with cyclic-imide peptidomimetics derivative CIP-13F inhibits the growth of human ovarian carcinoma cells.
    Cui SX; Qu XJ; Gao ZH; Zhang YS; Zhang XF; Zhao CR; Xu WF; Li QB; Han JX
    Cancer Lett; 2010 Jun; 292(2):153-62. PubMed ID: 20042271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of novel amino acid ureido derivatives as aminopeptidase N/CD13 inhibitors.
    Su L; Jia Y; Zhang L; Xu Y; Fang H; Xu W
    Bioorg Med Chem; 2012 Jun; 20(12):3807-15. PubMed ID: 22607877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and SAR studies of tripeptide analogs with the scaffold 3-phenylpropane-1,2-diamine as aminopeptidase N/CD13 inhibitors.
    Shang L; Fang H; Zhu H; Wang X; Wang Q; Mu J; Wang B; Kishioka S; Xu W
    Bioorg Med Chem; 2009 Apr; 17(7):2775-84. PubMed ID: 19299146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells.
    Terauchi M; Kajiyama H; Shibata K; Ino K; Nawa A; Mizutani S; Kikkawa F
    BMC Cancer; 2007 Jul; 7():140. PubMed ID: 17655775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of a novel series of L-isoserine derivatives as aminopeptidase N inhibitors.
    Yang K; Fen J; Fang H; Zhang L; Gong J; Xu W
    J Enzyme Inhib Med Chem; 2012 Apr; 27(2):302-10. PubMed ID: 21770859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel potent 2,5-pyrrolidinedione peptidomimetics as aminopeptidase N inhibitors. Design, synthesis and activity evaluation.
    Li Q; Fang H; Wang X; Hu G; Wang Q; Xu W
    Bioorg Med Chem Lett; 2012 Jan; 22(2):850-3. PubMed ID: 22206607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LYP3, a new bestatin derivative for aminopeptidase N inhibition.
    Luan Y; Ma C; Sui Z; Wang X; Feng J; Liu N; Jing F; Wang Y; Li M; Fang H; Xu W
    Med Chem; 2011 Jan; 7(1):32-6. PubMed ID: 21235517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of aminopeptidase N in enhanced chemosensitivity to paclitaxel in ovarian carcinoma in vitro and in vivo.
    Yamashita M; Kajiyama H; Terauchi M; Shibata K; Ino K; Nawa A; Mizutani S; Kikkawa F
    Int J Cancer; 2007 May; 120(10):2243-50. PubMed ID: 17266036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor angiogenesis effect of aminopeptidase inhibitor bestatin against B16-BL6 melanoma cells orthotopically implanted into syngeneic mice.
    Aozuka Y; Koizumi K; Saitoh Y; Ueda Y; Sakurai H; Saiki I
    Cancer Lett; 2004 Dec; 216(1):35-42. PubMed ID: 15500947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel aminopeptidase N inhibitors derived from 1,3,4-thiadiazole scaffold.
    Tu G; Li S; Huang H; Li G; Xiong F; Mai X; Zhu H; Kuang B; Xu WF
    Bioorg Med Chem; 2008 Jul; 16(14):6663-8. PubMed ID: 18571419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and preliminary activity evaluation of novel 3-amino-2-hydroxyl-3-phenylpropanoic acid derivatives as aminopeptidase N/CD13 inhibitors.
    Zhang X; Zhang L; Zhang J; Feng J; Yuan Y; Fang H; Xu W
    J Enzyme Inhib Med Chem; 2013 Jun; 28(3):545-51. PubMed ID: 22380779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and QSAR studies of novel lysine derives as amino-peptidase N/CD13 inhibitors.
    Wang Q; Chen M; Zhu H; Zhang J; Fang H; Wang B; Xu W
    Bioorg Med Chem; 2008 May; 16(10):5473-81. PubMed ID: 18467109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.